The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Asian Joint Panel Discussion

B-cell malignancy including multiple myeloma

Sun. Oct 14, 2018 8:30 AM - 10:40 AM No.2 (Osaka International Convention Center, 5F Sub Hall)

Chairs: Junji Suzumiya (Shimane University Hospital, Innovative Cancer Center, Department Oncology・Hematology, Japan), Wichai Prayoonwiwat (Thai Society of HematologyPhramongkutklao Hospital, Thailand)

【E】

[APD-5] Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma (DLBCL), and prognostic significance of cell of origin (COO) in a Southeast Asian population

Michelle Limei Poon1,3, Xin Liu1, Eng Soo Yap1,2,3, Suk Teng Chin4, Anand Jeyasekharan1,5, Yen Lin Chee1, Esther Hl Chan1, Widanalage Sanjay Prasad De Mel1, Joanne Shu Xian Lee1,3, Yee Mei Lee6, Yi Ching Yuen7, Liang Piu Koh1,3 (1.Department of Haematology-Oncology, NCIS, NUHS, 2.Department of Lab Medicine, NUHS, 3.Department of Medicine, YLLSOM, NUS, 4.National Cancer Centre Singapore, 5.Cancer Science Institute of Singapore, NUS, 6.National University Cancer Institute, Oncology Nursing, NUHS, 7.Department of Pharmacy, NUH)

Dr Poon is a Senior Consultant at the Department of Haematology-Oncology. After receiving her undergraduate medical degree from the National University of Singapore in 2001, she continued her internal medicine training before obtaining her membership from the Royal College of Physicians of the United Kingdom in 2004. She then undertook her advanced specialist training in haematology and obtaining her membership from the Royal College of Pathologists of the United Kingdom for hematology in 2009. She continues to be active in both undergraduate and postgraduate training for hematology and is currently an assistant professor with the Department of Medicine, Yong Loo Lin School of Medicine.
Dr Poon has a special interest in lymphoproliferative disorders and hematopoietic stem cell transplantation. She underwent a one-year postdoctoral fellowship program at the MD Anderson Cancer Center in the USA in 2012 to pursue this interest, especially in the use of hematopoietic transplantation and immunotherapy to treat lymphomas. Since her return, she has been actively involved in investigator initiated and pharmaceutical sponsored trials for lymphoproliferative disorders and hematopoietic transplantation. Her present research interests are in using novel clinical therapies for the management of patients with lymphoid malignancies (especially acute lymphoblastic leukemia and lymphoma) as well as clinical haematopoietic stem cell transplantation for adults with haematological diseases. She has also published in several peer reviewed journals, and presented at regional and international meetings.
Education and Fellowships
MBBS, MRCP, FRCPath (UK)
Specialty Interests
・Acute lymphoblastic leukaemia
・Lymphoma
・Autologous and allogeneic haematopoietic stem cell transplantation (related and alternative donor)

Abstract password authentication.
Password is written on a program and abstract book.

Password